Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.081 | 0.005 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.14 | 0.006 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.008 |